ClinicalTrials.gg
RecruitingNCT05069441Updated Mar 23, 2026

Prediction of Extubation Failure: A Multicenter Prospective Observational Study

An observational study in Mechanical Ventilation, sponsored by Chongqing Medical University. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-23.

Sponsored by Chongqing Medical University · Observational

How we know

From the registry’s dates

  • Started Oct 2021; still recruiting 5 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
2,604
Ages
18 Years and older
Sex
All
01

Study summary

The investigators intend to collect several variables to predict extubation failure among patients who successfully complete a spontaneous breathing trial, and then develop a scale using simple bedside indicators to predict extubation failure.

Read the detailed description

Mechanically ventilated patients who successfully completed a spontaneous breathing trial and prepared for extubation are eligible to enroll in this study. The vital signs, arterial blood gas tests, cough strength, cuff leak test, use of noninvasive ventilation et al. are collected. Patients are followed up to postextubation 28-day or discharge. Extubation failure is defined as reintubatin or death within postextubation 7 days. First, we will analyze the data to predict extubation failure. Then, we will combine several easily obtained variables to develop and validate a scale to predict extubation failure. Finally, we explore the predictive power of extubation failure tested by the scale and find the cutoff value to distinguish the low, moderate and high risk of extubation failure.

02

Conditions studied

  • Mechanical Ventilation

Keywords

  • Extubation Failure
03

In context

Lead sponsor

Chongqing Medical University is the lead sponsor of 78 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The population is that the patients who passed a spontaneous breathing trial and readiness for extubation.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Prepared for extubation through spontaneous breathing trial;Oral or nasal endotracheal intubation; be at least 18 years old

Exclusion criteria

Exclusion Criteria:

  • Extubation without a spontaneous breathing trial ;Reintubation due to secondary surgery; Tracheotomy
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
2,604 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients with extubation after a weaning trial

    Patients who sucessfully complete a spontaneous breathing trial are enrolled in this group.

06

What researchers measure

Primary outcomes

  1. Rate of extubation failure

    Extubation failure was defined as the reintubation or death

    Time frame: From extubation to 48 hours

  2. Rate of extubation failure

    Extubation failure was defined as the reintubation or death

    Time frame: From extubation to 7 days

  3. Rate of extubation failure

    Extubation failure was defined as the reintubation or death

    Time frame: From extubation to 28 days

Secondary outcomes

  1. Rate of mortality

    Mortality in ICU and hospital

    Time frame: From extubation to 28 days

  2. ICU stay

    Length of ICU stay

    Time frame: From extubation to 28 days

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2021 (actual). Primary completion is estimated for Dec 2026, 62 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 25, 2021
First posted
Oct 6, 2021
StartActual
Oct 15, 2021
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Mar 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05069441
Lead sponsor
Chongqing Medical University
Responsible party
Duan jun (Principal Investigator, Chongqing Medical University) — Principal investigator
First posted
Oct 6, 2021
Start date
Oct 15, 2021
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Mar 23, 2026

Study contacts

Jun Duan, Dr
Contact
duanjun412589@163.com
89012017
Linfu Bai, Dr
Contact
1023762525@qq.com
89012680
Jun Duan
principal investigator · First Affiliated Hospital of Chongqing Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion